Beijing
688621.SSBeijing Sun-Novo Pharmaceutical Research Co., Ltd. Price (688621.SS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
111,974,207
(0.023)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
Beijing Sun-Novo Pharmaceutical Research Co., Ltd.Currency: CNY
| YEAR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
36,049,906.00
+0% |
134,795,900.00
+274% |
233,525,568.00
+73% |
347,356,373.00
+49% |
493,646,453.00
+42% |
676,606,392.00
+37% |
932,120,362.00
+38% |
||||||||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 21,730,597.00 | 77,662,322.00 | 126,355,819.00 | 175,023,473.00 | 229,965,488.00 | 301,148,444.00 | 403,771,002.00 | ||||||||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
14,319,309.00
+0% |
57,133,578.00
+299% |
107,169,749.00
+88% |
172,332,900.00
+61% |
263,680,965.00
+53% |
375,457,948.00
+42% |
528,349,360.00
+41% |
||||||||||||
| Gross Profit Ratio | (0.40%) | (0.42%) | (0.46%) | (0.50%) | (0.53%) | (0.55%) | (0.57%) | ||||||||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 2,804,852.00 | 8,460,564.00 | 19,065,504.00 | 34,192,321.00 | 47,577,000.00 | 89,685,673.00 | 123,683,865.00 | ||||||||||||
| General and Administrative | 906,670.00 | 3,126,231.00 | 5,060,739.00 | 9,740,668.00 | 11,350,884.00 | 15,529,868.00 | 17,410,481.00 | ||||||||||||
| Selling, General & Admin... | 2,100,644.00 | 6,378,853.00 | 11,059,432.00 | 18,450,950.00 | 28,381,761.00 | 35,802,872.00 | 44,060,723.00 | ||||||||||||
| Selling & Marketing Exp... | 1,193,973.00 | 3,252,621.00 | 5,998,693.00 | 8,710,281.00 | 17,030,877.00 | 20,273,004.00 | 26,650,241.00 | ||||||||||||
| Depreciation and Amortiz... | 2,250,107.00 | 6,335,500.00 | 10,526,900.00 | 14,836,669.00 | 33,385,949.00 | 52,839,976.00 | 44,929,262.00 | ||||||||||||
| Other Expenses | -30,206.23 | -349,925.77 | 23,995,244.00 | 33,684,433.00 | 52,909,055.00 | 60,110,097.00 | 166,443,477.00 | ||||||||||||
| Total Operating Expenses | 12,056,459.00 | 28,722,724.00 | 54,120,181.00 | 86,327,704.00 | 128,867,818.00 | 185,598,643.00 | 334,188,065.00 | ||||||||||||
| Cost and Exponses | 33,787,056.00 | 106,385,047.00 | 180,476,001.00 | 261,351,178.00 | 358,833,306.00 | 486,747,087.00 | 737,959,067.00 | ||||||||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
1,152,798.00
+0% |
23,630,808.00
+1,950% |
55,041,742.00
+133% |
82,784,269.00
+50% |
122,590,710.00
+48% |
169,274,053.00
+38% |
194,161,295.00
+15% |
||||||||||||
| Operating Income Ratio | (0.03%) | (0.18%) | (0.24%) | (0.24%) | (0.25%) | (0.25%) | (0.21%) | ||||||||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 1,140,740.00 | 1,398,688.00 | 456,748.00 | 216,155.00 | 841,663.00 | 6,151,745.00 | 7,240,100.00 | ||||||||||||
| Interest Expenses | 848,210.00 | 2,078,574.00 | 750,786.00 | 1,040,161.00 | 3,564,863.00 | 9,699,943.00 | 12,178,142.00 | ||||||||||||
| Total Other Income/Exp... | -30,206.00 | -349,926.00 | -586,347.00 | -500,555.00 | -489,832.00 | -136,279.00 | -764,519.00 | ||||||||||||
| EBITDA | |||||||||||||||||||
| EBITDA | 4,220,909.00 | 30,683,616.00 | 65,758,749.00 | 93,776,273.00 | 159,096,772.00 | 231,859,665.00 | 250,504,181.00 | ||||||||||||
| EBITDA ratio | (0.16%) | (0.26%) | (0.26%) | (0.28%) | (0.33%) | (0.35%) | (0.27%) | ||||||||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | 1,122,592.00 | 23,280,882.00 | 54,455,395.00 | 82,283,714.00 | 122,100,878.00 | 169,137,774.00 | 193,396,776.00 | ||||||||||||
| Income Before Tax Ratio | (0.03%) | (0.17%) | (0.23%) | (0.24%) | (0.25%) | (0.25%) | (0.21%) | ||||||||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | 1,173.13 | 3,120,045.00 | 6,522,315.00 | 8,121,079.00 | 13,308,853.00 | 11,097,677.00 | 10,501,753.00 | ||||||||||||
| Net Income | |||||||||||||||||||
| Net Income | 1,980,489.00
+0% |
20,717,532.00
+946% |
47,400,670.00
+129% |
72,464,891.00
+53% |
105,662,439.00
+46% |
156,472,516.00
+48% |
184,757,441.00
+18% |
||||||||||||
| Net Income Ratio | (0.05%) | (0.15%) | (0.20%) | (0.21%) | (0.21%) | (0.23%) | (0.20%) | ||||||||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | 0.02 | 0.25 | 0.42 | 0.65 | 0.94 | 1.39 | 1.65 | ||||||||||||
| Diluted EPS | 0.02 | 0.25 | 0.42 | 0.65 | 0.94 | 1.39 | 1.65 | ||||||||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 92,422,829.00 | 82,870,132.00 | 112,000,001.00 | 112,000,001.00 | 112,000,001.00 | 112,000,001.00 | 111,974,207.00 | ||||||||||||
| Diluted Share Outstanding | 92,422,829.00 | 82,870,132.00 | 112,000,001.00 | 112,000,001.00 | 112,000,001.00 | 112,000,001.00 | 111,974,207.00 | ||||||||||||